Skip to content
TrialScanner

NCT04570839

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

Phase 1/Phase 2CompletedCGENLeadBMYCollaborator

Registry record

Lead sponsor
Compugen Ltd
Conditions
Endometrial Neoplasms; Ovarian Cancer; Solid Tumor; Head and Neck Cancer
Primary completion
May 15, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04570839 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04570839: COM701 in Combination With... | TrialScanner